Monika Długosz-Danecka

7PUBLICATIONS
24CO-AUTHORS
Immunology not elsewhere classifiedInfectious diseasesHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 12, 2022
Bing-Neel Syndrome, a Rare Presentation of Waldenström Macroglobulinemia-A Multicenter Report by the Polish Lymphoma Research Group.

Joanna Drozd-Sokołowska, Anna Waszczuk-Gajda, Magdalena Witkowska

|Feb 15, 2022
Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia.

Bartosz Puła, Katarzyna Pruszczyk, Ewa Pietrusza

|Jan 11, 2021
Acalabrutinib: a highly selective, potent Bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia.

Paolo Ghia, Monika Dlugosz-Danecka, Lydia Scarfò

|Apr 21, 2020
Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients.

Sarah Goldman-Mazur, Artur Jurczyszyn, Jorge J Castillo

|Apr 10, 2019
Consolidation with 90Y ibritumomab tiuxetan radioimmunotherapy in mantle cell lymphoma patients ineligible for high dose therapy: results of the phase II multicentre Polish Lymphoma Research Group trial, after 8-year long follow-up.

Wojciech Jurczak, Alicja M Gruszka, Anna Sowa Staszczak

|Feb 01, 2019
Treatment of aggressive B-cell non-Hodgkin lymphoma beyond frontline therapy in patients not eligible for stem cell transplantation: a structured review.

Gilles A Salles, Ruth Pettengell, Raul Cordoba

Pageof 2

Frequent Collaborators

2 joint publications

Wojciech Jurczak

2 joint publications

Anna Waszczuk-Gajda

2 joint publications

Joanna Drozd-Sokołowska

1 joint publications

Jorge J Castillo